Detalhe da pesquisa
1.
Low-Density Lipoprotein Receptor Is a Key Driver of Aggressiveness in Thyroid Tumor Cells.
Int J Mol Sci
; 24(13)2023 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37446330
2.
LDL, HDL and endocrine-related cancer: From pathogenic mechanisms to therapies.
Semin Cancer Biol
; 73: 134-157, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33249202
3.
Yap governs a lineage-specific neuregulin1 pathway-driven adaptive resistance to RAF kinase inhibitors.
Mol Cancer
; 21(1): 213, 2022 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36476495
4.
Cross-Talk between Inflammatory Mediators and the Epithelial Mesenchymal Transition Process in the Development of Thyroid Carcinoma.
Int J Mol Sci
; 20(10)2019 May 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31109060
5.
Lenvatinib-Loaded Poly(lactic-co-glycolic acid) Nanoparticles with Epidermal Growth Factor Receptor Antibody Conjugation as a Preclinical Approach to Therapeutically Improve Thyroid Cancer with Aggressive Behavior.
Biomolecules
; 13(11)2023 11 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38002329
6.
MiR-125b downregulates macrophage scavenger receptor type B1 and reverse cholesterol transport.
Biomed Pharmacother
; 146: 112596, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35062066
7.
Cholesterol and 27-hydroxycholesterol promote thyroid carcinoma aggressiveness.
Sci Rep
; 9(1): 10260, 2019 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31311983